Technological improvements in the near future using the nanostring technology will probably render the evaluation of the tumor‐associated macrophage count more robust and overcome some variability due to the use of different antibody clones (KP1 and PGM1), varying thresholds and inter‐observer differences 38. Here, PGM1 is linked to neoplasm.